Novaremed
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Novaremed has raised €129M across 2 funding rounds from 1 investor, most recently a round in Jul 2022. Based in Basel, Switzerland; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€129M
€129,322,705
Funding rounds
2
Investors
1
distinct backers
Active since
2020-09
latest 2022-07
Funding by year
EUR raised per yearNovaremed — funding by year — interactive chart.
Data table
| Novaremed — funding by year | |
|---|---|
| 2020 | €2.3M |
| 2022 | €127M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-25 | Other | €127M | NeuroFront Therapeutics | View deal → |
| 2020-09-21 | Other | €2.3M | — | View deal → |
Investors
1Related news
- Novaremed receives USD 130 million in exclusive license agreementstartupticker.ch · 2022-07
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData